SLC25A13 encodes citrin (aspartate/glutamate carrier 2, AGC2), the liver-type, calcium-binding member of the mitochondrial carrier (SLC25) family. It is an integral, multi-pass protein of the mitochondrial inner membrane that catalyzes the electrogenic exchange of L-aspartate for L-glutamate plus a proton: it exports L-aspartate from the mitochondrial matrix to the cytosol while importing cytosolic L-glutamate together with a proton. Because aspartate moves as the anion and glutamate is co-transported with a proton, the antiport is electrogenic and, in energized mitochondria, is driven in the direction of aspartate efflux. Citrin is a central component of the malate-aspartate NADH shuttle, transferring cytosolic reducing equivalents into the mitochondria and regenerating cytosolic NAD+, and it supplies the cytosolic aspartate consumed by argininosuccinate synthetase (ASS1) in the hepatic urea cycle and used in gluconeogenesis. Each protomer has a three-domain architecture: an N-terminal regulatory domain with EF-hand motifs (only EF-hand 2 binds calcium in the intermembrane space), a six-transmembrane SLC25 carrier domain that performs transport, and a C-terminal amphipathic helix; the full-length carrier assembles as a homodimer via the N-terminal domain while transporting substrate as a functional monomer. Citrin is expressed most abundantly in liver and other non-excitable tissues, in contrast to its paralog aralar (SLC25A12 / AGC1), the brain- and muscle-predominant isoform. Loss of citrin function causes citrin deficiency, which manifests across age as neonatal intrahepatic cholestasis (NICCD), failure to thrive and dyslipidemia (FTTDCD), and adult-onset citrullinemia type II (CTLN2) with hyperammonemic encephalopathy; the phenotype is broader than that of a pure urea cycle enzyme owing to citrin's additional role in the malate-aspartate shuttle and cellular redox balance.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005313
L-glutamate transmembrane transporter activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) assignment of L-glutamate transporter activity. Citrin imports L-glutamate together with a proton as one half of its aspartate/glutamate antiport, so this is a correct component of the core function.
Reason: Directly supported by experimental reconstitution showing electrogenic exchange of aspartate for glutamate and a proton. This activity is one arm of the aspartate/glutamate antiport; the more specific antiporter term (GO:0000515) is the primary/core molecular function, but this term is accurate.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0015183
L-aspartate transmembrane transporter activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) assignment of L-aspartate transporter activity. Citrin exports L-aspartate from the matrix as the other half of its antiport; a correct component of the core function.
Reason: Experimentally demonstrated. Aspartate efflux is one arm of the electrogenic aspartate/glutamate antiport (the core activity, GO:0000515). This transporter-activity term is accurate.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0043490
malate-aspartate shuttle
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) assignment placing citrin in the malate-aspartate NADH shuttle, which it participates in as the inner-membrane aspartate/glutamate exchange step.
Reason: Well supported: overexpression of citrin increases malate-aspartate shuttle activity in human cells, and the carrier is an integral component of the shuttle. Core biological process for citrin.
Supporting Evidence:
PMID:11566871
Overexpression of the carriers in transfected human cells increased the activity of the malate/aspartate NADH shuttle
|
|
GO:0005743
mitochondrial inner membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) assignment to the mitochondrial inner membrane, where citrin is active as a multi-pass carrier. Correct and core subcellular location.
Reason: Consistent with all experimental localization data and the multi-pass topology of the SLC25 carrier domain. Core location.
Supporting Evidence:
PMID:39419476
located in the mitochondrial inner membrane
|
|
GO:0015810
aspartate transmembrane transport
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) BP assignment for aspartate transmembrane transport, the process arm of citrin's aspartate efflux.
Reason: Experimentally supported process term corresponding to the aspartate half of the antiport. Accurate.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0015813
L-glutamate transmembrane transport
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) BP assignment for L-glutamate transmembrane transport, the process arm of citrin's glutamate import.
Reason: Experimentally supported process term corresponding to the glutamate half of the antiport. Accurate.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0000514
3-sulfino-L-alanine: proton, glutamate antiporter activity
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: ARBA electronic annotation for cysteinesulfinate (3-sulfino-L-alanine) / glutamate, proton antiport. Citrin exchanges cysteinesulfinate with glutamate and a proton experimentally; correct but a secondary (non-core) substrate.
Reason: Experimentally demonstrated as a secondary substrate exchange, but aspartate/glutamate antiport (GO:0000515) is the physiologically central function. Real but ancillary.
Supporting Evidence:
PMID:11566871
AGC also transports cysteinesulfinate in exchange for either aspartate or glutamate
|
|
GO:0000515
aspartate:glutamate, proton antiporter activity
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ARBA electronic annotation for the aspartate:glutamate, proton antiporter activity, the primary catalytic function of citrin. Duplicated by an EXP and an IDA annotation.
Reason: The primary/core molecular function of citrin, directly demonstrated by reconstitution and independently confirmed. The electronic annotation is correct.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0005509
calcium ion binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation (InterPro EF-hand) for calcium ion binding. Citrin has a regulatory N-terminal EF-hand domain; the structure confirms calcium binding at EF-hand 2.
Reason: Supported by X-ray structure showing calcium bound at EF-hand 2. Calcium binding is a genuine molecular activity of the regulatory domain.
Supporting Evidence:
PMID:25410934
Only EF-hand 2 binds calcium
|
|
GO:0005743
mitochondrial inner membrane
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation (multiple IEA methods / UniProt SubCell) for mitochondrial inner membrane localization. Correct and duplicated by EXP/IDA annotations.
Reason: Consistent with experimental subcellular localization. Core location.
Supporting Evidence:
PMID:39419476
located in the mitochondrial inner membrane
|
|
GO:0015804
neutral amino acid transport
|
IEA
GO_REF:0000108 |
MODIFY |
Summary: Inter-ontology (GO_REF:0000108) inference from the cysteinesulfinate antiport term GO:0000514, classifying cysteinesulfinate transport as neutral amino acid transport.
Reason: Citrin's physiological substrates aspartate and glutamate are acidic (anionic) amino acids, not neutral amino acids. This term is a logical by-product of the secondary cysteinesulfinate activity and mischaracterizes the core function; better captured by the aspartate/glutamate transport terms.
Proposed replacements:
aspartate transmembrane transport
L-glutamate transmembrane transport
|
|
GO:0043490
malate-aspartate shuttle
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ARBA electronic annotation to the malate-aspartate shuttle, duplicating the IBA and IDA annotations to this term.
Reason: Correct; the malate-aspartate shuttle is a core biological process for citrin, independently supported by experimental data.
Supporting Evidence:
PMID:11566871
Overexpression of the carriers in transfected human cells increased the activity of the malate/aspartate NADH shuttle
|
|
GO:0051592
response to calcium ion
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: ARBA electronic annotation for response to calcium ion, reflecting calcium stimulation of citrin transport activity via its EF-hand domain.
Reason: Citrin transport is stimulated by calcium binding at the intermembrane-space EF-hand domain, so a response-to-calcium annotation has an experimental basis. However this is a regulatory/response process rather than citrin's core transport function. Retain as non-core.
Supporting Evidence:
PMID:11566871
stimulated by Ca
|
|
GO:0055085
transmembrane transport
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro2GO electronic annotation to the generic transmembrane transport process from the mitochondrial carrier domain signature.
Reason: Correct but very general parent term. The specific aspartate/glutamate transport processes and the malate-aspartate shuttle capture the core function; this broad term is a valid, non-core ancestor.
|
|
GO:0070778
L-aspartate transmembrane transport
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation (from the aspartate transporter/antiporter MF terms) for L-aspartate transmembrane transport, the process arm of citrin's aspartate efflux.
Reason: Accurate specific process term for aspartate transport, consistent with the experimentally demonstrated aspartate efflux activity.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:1902600
proton transmembrane transport
|
IEA
GO_REF:0000108 |
KEEP AS NON CORE |
Summary: Inter-ontology inference (from GO:0000514) that citrin is involved in proton transmembrane transport, reflecting co-transport of a proton with glutamate.
Reason: Citrin co-transports a proton with glutamate, so proton translocation is part of its electrogenic mechanism; not wrong, but a mechanistic by-product rather than the primary amino-acid antiport function. Retain as non-core.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: High-throughput interactome (IPI) annotation with the paralog SLC25A12 / aralar (O75746) as the recorded partner. Uninformative bare protein-binding term.
Reason: Per curation guidelines, bare protein binding conveys no specific function. The recorded partner is the paralog SLC25A12, consistent with the mitochondrial-carrier context, but this generic term does not describe citrin's molecular function. The informative interaction (homodimerization) is captured by GO:0042802.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: High-throughput interactome (IPI) annotation with the paralog SLC25A12 (O75746). Uninformative bare protein-binding term.
Reason: Bare protein binding is uninformative and is discouraged. Duplicate large-scale interactome hit against the paralog SLC25A12; does not add functional specificity.
|
|
GO:0005515
protein binding
|
IPI
PMID:40355756 The solute carrier superfamily interactome. |
MARK AS OVER ANNOTATED |
Summary: Solute carrier interactome (IPI) annotation with the paralog SLC25A12 (O75746). Uninformative bare protein-binding term.
Reason: Bare protein binding is uninformative. Large-scale SLC interactome hit against the paralog SLC25A12; no specific molecular function conveyed.
|
|
GO:0005313
L-glutamate transmembrane transporter activity
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Ensembl-Compara (GO_REF:0000107) orthology transfer from mouse Slc25a13 (Q9QXX4) of L-glutamate transporter activity. Duplicates the IBA annotation to this term.
Reason: Correct: glutamate import is one arm of citrin's antiport, well supported experimentally. The orthology transfer is appropriate.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ensembl-Compara orthology transfer of mitochondrion localization. Correct but less specific than the mitochondrial inner membrane annotations.
Reason: Accurate but a broad parent of the specific mitochondrial inner membrane location that is the core annotation. Retain as non-core.
Supporting Evidence:
PMID:39419476
located in the mitochondrial inner membrane
|
|
GO:0006094
gluconeogenesis
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ensembl-Compara orthology transfer for involvement in gluconeogenesis, reflecting the requirement for cytosolic aspartate (supplied by citrin) in gluconeogenesis from lactate.
Reason: Citrin-supplied cytosolic aspartate is needed for the conversion of oxoglutarate to oxaloacetate in gluconeogenesis from lactate/alanine, so the process link is physiologically valid but downstream and tissue-context dependent rather than a core molecular function. Retain as non-core.
Supporting Evidence:
PMID:25410934
Cytosolic aspartate is also required for the conversion of oxoglutarate to oxaloacetate, a crucial step in gluconeogenesis from lactate and alanine
|
|
GO:0015172
acidic amino acid transmembrane transporter activity
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ensembl-Compara orthology transfer of acidic amino acid transmembrane transporter activity, a parent term covering the transport of the acidic amino acids aspartate and glutamate.
Reason: Correct as a broader (parent) molecular function: aspartate and glutamate are acidic amino acids. The specific aspartate:glutamate antiporter activity (GO:0000515) and the individual aspartate/glutamate transporter terms are the core annotations; this generalization is a valid non-core ancestor.
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
KEEP AS NON CORE |
Summary: Immunofluorescence-based (HPA, IDA) mitochondrial localization. Consistent with the established mitochondrial inner-membrane location.
Reason: Correct but less specific than mitochondrial inner membrane; retain as non-core. Human Protein Atlas reports SLC25A13 as tissue-enriched in liver with mitochondrial staining.
|
|
GO:0000515
aspartate:glutamate, proton antiporter activity
|
EXP
PMID:38945283 The mitochondrial aspartate/glutamate carrier does not trans... |
ACCEPT |
Summary: Experimental (EXP) confirmation of aspartate:glutamate, proton antiporter activity. Reconfirmed the canonical antiport and showed citrin does NOT transport GABA, sharpening substrate specificity.
Reason: Directly supports the primary/core molecular function; additionally excludes GABA as a substrate, refining specificity of the antiport.
Supporting Evidence:
PMID:38945283
the human AGC isoforms (AGC1/aralar1 and AGC2/citrin) are unable to transport GABA both in homo- and in hetero-exchange with either glutamate or aspartate, i.e. the canonical substrates of AGC
|
|
GO:0005743
mitochondrial inner membrane
|
EXP
PMID:10642534 Characterization of a second member of the subfamily of calc... |
ACCEPT |
Summary: Experimental localization of citrin (Aralar2) to mitochondria in human cell lines. Core location, duplicated by other EXP/IDA/IBA annotations.
Reason: The mitochondrial localization of citrin was experimentally established in this characterization study; it is the core subcellular location.
Supporting Evidence:
PMID:10642534
The localization of Aralar2/citrin expressed in human cell lines is mitochondrial
|
|
GO:0005743
mitochondrial inner membrane
|
EXP
PMID:39419476 Distinct roles for the domains of the mitochondrial aspartat... |
ACCEPT |
Summary: Experimental localization to the mitochondrial inner membrane, from the domain-dissection study of citrin (which also showed N-terminal mutations cause a mitochondrial import defect). Core location.
Reason: Directly supported experimental annotation of the core inner-membrane location.
Supporting Evidence:
PMID:39419476
located in the mitochondrial inner membrane
|
|
GO:0043490
malate-aspartate shuttle
|
IGI
PMID:37647199 The malate-aspartate shuttle is important for de novo serine... |
ACCEPT |
Summary: Genetic-interaction (IGI) annotation from a panel of malate-aspartate-shuttle-deficient cell lines showing the shuttle (including its AGC component) is important for de novo serine biosynthesis. Places citrin in the malate-aspartate shuttle.
Reason: The malate-aspartate shuttle is a core biological process for citrin. This genetic study of MAS components (full text assessed by the curator) supports the shuttle involvement; the abstract confirms the MAS focus. Consistent with the IBA/IDA annotations to the same term.
Supporting Evidence:
PMID:37647199
we show that the MAS is important for de novo serine biosynthesis
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
KEEP AS NON CORE |
Summary: High-throughput proteomics (HTP) placement of SLC25A13 in the mitochondrion (high-confidence mitochondrial proteome). Consistent with the established mitochondrial inner-membrane location.
Reason: Correct but broader than the specific mitochondrial inner-membrane location; a proteome-scale mitochondrial call. Retain as non-core.
|
|
GO:0000514
3-sulfino-L-alanine: proton, glutamate antiporter activity
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
KEEP AS NON CORE |
Summary: Direct experimental (IDA) demonstration that citrin exchanges cysteinesulfinate (3-sulfino-L-alanine) for glutamate and a proton. A genuine but secondary substrate activity.
Reason: Experimentally demonstrated secondary substrate exchange. Physiologically the aspartate/glutamate antiport (GO:0000515) is central; cysteinesulfinate exchange is ancillary. Retain as accurate but non-core.
Supporting Evidence:
PMID:11566871
AGC also transports cysteinesulfinate in exchange for either aspartate or glutamate
|
|
GO:0000515
aspartate:glutamate, proton antiporter activity
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
ACCEPT |
Summary: Direct experimental (IDA) demonstration of the electrogenic aspartate:glutamate, proton antiport by reconstituted citrin. The defining, core molecular function.
Reason: The foundational experimental evidence for citrin's core function: reconstituted protein catalyzes electrogenic exchange of aspartate for glutamate and a proton. Primary molecular function.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0005743
mitochondrial inner membrane
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
ACCEPT |
Summary: Direct experimental (IDA) inner-membrane localization with defined multi-pass topology (N- and C-terminal domains in the intermembrane space; six-TM carrier domain). Core location.
Reason: Directly supported experimental annotation of the core inner-membrane location and topology.
Supporting Evidence:
PMID:11566871
Ca(2+)-stimulated aspartate/glutamate transporters
|
|
GO:0005509
calcium ion binding
|
IDA
PMID:25410934 Calcium-induced conformational changes of the regulatory dom... |
ACCEPT |
Summary: Direct experimental (IDA) calcium binding, from the X-ray structure of the citrin N-terminal domain showing calcium bound at EF-hand 2. Core molecular activity of the regulatory domain.
Reason: Crystallographic demonstration of calcium binding at EF-hand 2. Calcium binding by the regulatory EF-hand domain is a genuine, core molecular function of citrin.
Supporting Evidence:
PMID:25410934
Only EF-hand 2 binds calcium
|
|
GO:0042802
identical protein binding
|
IDA
PMID:25410934 Calcium-induced conformational changes of the regulatory dom... |
KEEP AS NON CORE |
Summary: Direct experimental (IDA) identical protein binding, reflecting the demonstrated homodimerization of citrin via its N-terminal domain (SEC-MALLS and the dimeric crystal structure).
Reason: Citrin forms a homodimer via the N-terminal domain, so identical protein binding is experimentally supported and more informative than bare protein binding. However dimerization is a structural property rather than the core transport function (the carrier transports substrate as a functional monomer). Retain as non-core.
Supporting Evidence:
PMID:25410934
demonstrating that the full-length carrier was dimeric
|
|
GO:0006839
mitochondrial transport
|
NAS
PMID:10642534 Characterization of a second member of the subfamily of calc... |
KEEP AS NON CORE |
Summary: Non-traceable author statement (NAS) that citrin functions in mitochondrial transport, from the initial characterization describing it as a calcium-regulated mitochondrial metabolite carrier.
Reason: Correct but very general. The specific aspartate/glutamate antiport and its downstream processes (malate-aspartate shuttle, aspartate/glutamate transport) capture the core function; this broad process term is a valid non-core ancestor.
Supporting Evidence:
PMID:10642534
function as calcium-regulated metabolite (possibly anionic) carriers
|
|
GO:0005743
mitochondrial inner membrane
|
TAS
Reactome:R-HSA-372448 |
ACCEPT |
Summary: Traceable author statement (Reactome) for mitochondrial inner-membrane localization, from the Reactome reaction in which SLC25A12/13 exchange L-Glu and L-Asp. Core location.
Reason: Reactome curation consistent with all experimental localization data. Core inner-membrane location.
|
|
GO:0005509
calcium ion binding
|
IDA
PMID:10642534 Characterization of a second member of the subfamily of calc... |
ACCEPT |
Summary: Direct experimental (IDA) calcium binding from the initial characterization, where the N-terminal half of citrin was shown to bind calcium (requiring the two most distal EF-hands). Core molecular activity of the regulatory domain.
Reason: Experimentally demonstrated calcium binding by the N-terminal EF-hand domain. Duplicates the structurally-supported IDA calcium-binding annotation.
Supporting Evidence:
PMID:10642534
The N-terminal half of Aralar2/citrin is able to bind calcium and this requires the presence of the two most distal EF-hands
|
|
GO:0005739
mitochondrion
|
IDA
PMID:10642534 Characterization of a second member of the subfamily of calc... |
KEEP AS NON CORE |
Summary: Direct experimental (IDA) mitochondrial localization of citrin expressed in human cell lines. Consistent with the inner-membrane location; broader term.
Reason: Accurate but a broad parent of the specific mitochondrial inner membrane location. Retain as non-core.
Supporting Evidence:
PMID:10642534
The localization of Aralar2/citrin expressed in human cell lines is mitochondrial
|
|
GO:0005743
mitochondrial inner membrane
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity (ISS) transfer from mouse Slc25a13 (Q9QXX4) of inner-membrane localization. Correct and duplicated by EXP/IDA/IBA annotations.
Reason: Consistent with all experimental localization data. Core location.
Supporting Evidence:
PMID:39419476
located in the mitochondrial inner membrane
|
|
GO:0005886
plasma membrane
|
NAS
PMID:10642534 Characterization of a second member of the subfamily of calc... |
REMOVE |
Summary: Non-traceable author statement (NAS) placing citrin at the plasma membrane. Contradicts the extensive experimental evidence for a mitochondrial inner-membrane localization, including the conclusion of the same cited paper.
Reason: Citrin is an integral protein of the mitochondrial inner membrane; there is no experimental support for a plasma-membrane location, and the cited characterization study itself concludes the localization is mitochondrial. This NAS annotation is inconsistent with established biology and should be removed.
Supporting Evidence:
PMID:10642534
The localization of Aralar2/citrin expressed in human cell lines is mitochondrial
|
|
GO:0006754
ATP biosynthetic process
|
IDA
PMID:12851387 Recombinant expression of the Ca(2+)-sensitive aspartate/glu... |
KEEP AS NON CORE |
Summary: Direct experimental (IDA) annotation that recombinant citrin increases mitochondrial ATP production in agonist-stimulated cells, linking its calcium-sensitive transport activity to mitochondrial energy metabolism.
Reason: Experimentally supported: citrin overexpression raises mitochondrial ATP upon calcium-mobilizing agonist stimulation, via its role in the malate-aspartate shuttle feeding reducing equivalents to oxidative phosphorylation. This is a downstream physiological consequence rather than citrin's direct molecular function; retain as non-core.
Supporting Evidence:
PMID:12851387
larger in cells expressing aralar and citrin
|
|
GO:0045333
cellular respiration
|
IDA
PMID:12851387 Recombinant expression of the Ca(2+)-sensitive aspartate/glu... |
KEEP AS NON CORE |
Summary: Direct experimental (IDA) annotation linking citrin to cellular respiration through its calcium-stimulated enhancement of mitochondrial ATP production and aerobic metabolism.
Reason: Citrin contributes to aerobic/oxidative metabolism by feeding cytosolic reducing equivalents into mitochondria via the malate-aspartate shuttle, and its overexpression stimulates mitochondrial ATP on agonist stimulation. Downstream physiological role rather than a core molecular function; retain as non-core.
Supporting Evidence:
PMID:12851387
the stimulation of aerobic metabolism
|
|
GO:0005739
mitochondrion
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
KEEP AS NON CORE |
Summary: Direct experimental (IDA) mitochondrial localization from the functional reconstitution study. Consistent with the inner-membrane location; broader term.
Reason: Accurate but a broad parent of the specific mitochondrial inner membrane location. Retain as non-core.
Supporting Evidence:
PMID:11566871
Ca(2+)-stimulated aspartate/glutamate transporters
|
|
GO:0015810
aspartate transmembrane transport
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
ACCEPT |
Summary: Direct experimental (IDA) aspartate transmembrane transport, the process arm of citrin's aspartate efflux, demonstrated by reconstitution.
Reason: Experimentally supported specific process term for aspartate transport (the aspartate half of the antiport). Accurate.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0015813
L-glutamate transmembrane transport
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
ACCEPT |
Summary: Direct experimental (IDA) L-glutamate transmembrane transport, the process arm of citrin's glutamate import, demonstrated by reconstitution.
Reason: Experimentally supported specific process term for glutamate transport (the glutamate half of the antiport). Accurate.
Supporting Evidence:
PMID:11566871
shown to catalyze the electrogenic exchange of aspartate for glutamate and a H
|
|
GO:0043490
malate-aspartate shuttle
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
ACCEPT |
Summary: Direct experimental (IDA) annotation to the malate-aspartate shuttle: citrin overexpression increased malate-aspartate shuttle activity in human cells. Core biological process.
Reason: Foundational experimental evidence that citrin is a component of the malate-aspartate NADH shuttle. Core biological process.
Supporting Evidence:
PMID:11566871
Overexpression of the carriers in transfected human cells increased the activity of the malate/aspartate NADH shuttle
|
|
GO:0051592
response to calcium ion
|
IDA
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
KEEP AS NON CORE |
Summary: Direct experimental (IDA) annotation for response to calcium ion: citrin transport activity is stimulated by calcium on the external face of the inner membrane, where its EF-hand domains reside.
Reason: Experimentally supported calcium stimulation of transport, a genuine regulatory response. However it is a regulatory process rather than citrin's core transport function, and the physiological significance of the calcium regulation has since been debated. Retain as non-core.
Supporting Evidence:
PMID:11566871
stimulated by Ca
|
|
GO:0000050
urea cycle
|
TAS
PMID:11566871 Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate... |
NEW |
Summary: Proposed new annotation. Citrin supplies the cytosolic aspartate consumed by argininosuccinate synthetase (ASS1) in the hepatic urea cycle; loss of this supply underlies the argininosuccinate synthetase deficiency and citrullinemia of citrin deficiency. Central role documented but not currently in the GOA for SLC25A13.
Reason: The urea cycle role is a defining, textbook function of citrin and mechanistically explains citrullinemia type II, yet no urea cycle (GO:0000050) annotation exists in the current GOA. Adding it captures a core biological process. Supported by the primary functional paper and the structural review.
Supporting Evidence:
PMID:11566871
urea cycle and the aspartate/malate NADH shuttle
PMID:25410934
In liver, cytosolic aspartate is required for the urea cycle
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
SLC25A13 (Solute Carrier Family 25 Member 13; UniProt Q9UJS0) encodes the mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), commonly known as citrin. It is also referred to as ARALAR2 or calcium-binding mitochondrial carrier protein Aralar2 (palmieri2013themitochondrialtransporter pages 15-16, tavoulari2024distinctrolesfor pages 1-2). Citrin belongs to the SLC25 mitochondrial carrier family (TC 2.A.29), which comprises 53 members in humans that transport a wide variety of solutes across the inner mitochondrial membrane (kunji2025thepeculiarproperties pages 3-4, ruprecht2020theslc25mitochondrial pages 1-2). Citrin is one of two mammalian isoforms of aspartate/glutamate carriers, the other being aralar (AGC1/SLC25A12), which shares 78% sequence identity with citrin but differs markedly in tissue expression (gonzalezmoreno2023exogenousaralarslc25a12can pages 2-3).
The following table summarizes the key properties of SLC25A13/citrin:
| Property | Summary |
|---|---|
| Gene name | SLC25A13 (solute carrier family 25 member 13); also called AGC2 (aspartate/glutamate carrier 2) (palmieri2013themitochondrialtransporter pages 15-16, holecek2023aspartateglutamatecarrier2 pages 1-2) |
| Protein names / aliases | Citrin; electrogenic aspartate/glutamate antiporter SLC25A13; mitochondrial aspartate-glutamate carrier 2 (AGC2); ARALAR2 / aralar-related gene 2 (tavoulari2024distinctrolesfor pages 1-2, holecek2023aspartateglutamatecarrier2 pages 1-2) |
| UniProt ID | Q9UJS0 (user-provided UniProt identity; matched in literature to human SLC25A13/citrin/AGC2) (tavoulari2024distinctrolesfor pages 1-2, vukovic2024thetherapeuticlandscape pages 1-2) |
| Organism | Homo sapiens (human) (user-provided identity; disease and biochemical literature consistently describe human SLC25A13/citrin deficiency) (vukovic2024thetherapeuticlandscape pages 1-2, kido2024clinicallandscapeof pages 1-2) |
| Protein family | Member of the SLC25 mitochondrial carrier family; specifically an aspartate/glutamate carrier of the inner mitochondrial membrane (ruprecht2020theslc25mitochondrial pages 1-2, tavoulari2024distinctrolesfor pages 1-2) |
| Subcellular localization | Localized to the inner mitochondrial membrane; participates in metabolite exchange between mitochondrial matrix and cytosol/intermembrane-space-facing side (lacabanne2025currentunderstandingof pages 3-4, gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2) |
| Primary tissue expression | Highest functional importance in liver/hepatocytes, where it is the predominant or sole AGC isoform; also expressed in intestinal epithelium/small intestine; lower or restricted expression in kidney and heart, and low brain expression limited to select neuronal clusters (contreras2010lowlevelsof pages 1-2, broeks2021inborndisordersof pages 6-10, gonzalezmoreno2023exogenousaralarslc25a12can pages 2-3) |
| Transport substrates | Exports aspartate from the mitochondrial matrix in exchange for import of glutamate plus H+ into mitochondria (palmieri2013themitochondrialtransporter pages 15-16, tavoulari2024distinctrolesfor pages 1-2, broeks2021inborndisordersof pages 6-10) |
| Transport mechanism | Electrogenic aspartate/glutamate antiport operating by an alternating-access mechanism with matrix-open and cytoplasmic-open states, controlled by conserved salt-bridge gate networks; proton-coupled glutamate import helps drive net flux in the malate-aspartate shuttle (kunji2025thepeculiarproperties pages 3-4, ruprecht2020theslc25mitochondrial pages 1-2, lacabanne2025currentunderstandingof pages 4-6) |
| Key metabolic pathways | Core component of the malate-aspartate shuttle for cytosolic NADH reoxidation and mitochondrial NADH generation; supplies cytosolic aspartate for the urea cycle; supports gluconeogenesis via oxaloacetate/aspartate coupling; also supports protein, purine, and pyrimidine synthesis and broader hepatic redox/energy metabolism (holecek2023aspartateglutamatecarrier2 pages 1-2, holecek2023aspartateglutamatecarrier2 pages 2-4, palmieri2013themitochondrialtransporter pages 15-16) |
| Associated diseases | Biallelic pathogenic variants cause citrin deficiency (CD) with age-dependent phenotypes: NICCD (neonatal intrahepatic cholestasis caused by citrin deficiency), FTTDCD (failure to thrive and dyslipidemia caused by citrin deficiency), and CTLN2/AACD (adult-onset type II citrullinemia / adolescent-adult citrin deficiency); complications include hyperammonemia, fatty liver, pancreatitis, cirrhosis, and risk of hepatocellular carcinoma (vukovic2024thetherapeuticlandscape pages 1-2, komatsu2023citrindeficiencyclinical pages 1-2, kido2022clinicalmanifestationand pages 7-11) |
| Key structural features | Unusual three-domain mitochondrial carrier with an N-terminal EF-hand domain, a canonical carrier domain of three repeated modules/six transmembrane helices, and a C-terminal amphipathic helix; forms homodimers; recent work indicates only EF-hand 2 binds Ca2+ and that Ca2+ binding is not required for transport regulation, contrary to older models (tavoulari2024distinctrolesfor pages 1-2, lacabanne2025currentunderstandingof pages 3-4, tavoulari2024distinctrolesfor pages 11-12) |
Table: This table summarizes the key molecular, cellular, metabolic, and disease-related properties of human SLC25A13/citrin. It is useful as a quick reference linking transporter function and structure to citrin deficiency phenotypes.
Citrin functions as an electrogenic aspartate/glutamate antiporter embedded in the inner mitochondrial membrane. Its primary transport activity is the export of aspartate anions from the mitochondrial matrix into the cytosol, coupled with the import of cytosolic glutamate anions plus a proton (H⁺) into the matrix (palmieri2013themitochondrialtransporter pages 15-16, tavoulari2024distinctrolesfor pages 1-2, ruprecht2020theslc25mitochondrial pages 1-2). This co-transport of glutamate with a proton is driven by the mitochondrial proton motive force, which renders the shuttle practically unidirectional toward oxidation of cytosolic NADH, maintaining the cytosolic NAD⁺/NADH pool in a more oxidized state than the mitochondrial matrix pool (kunji2025thepeculiarproperties pages 3-4).
The electrogenic nature of this exchange—where aspartate carries a net negative charge of -1 and glutamate plus a proton is effectively neutral—means the transport is driven forward by the mitochondrial membrane potential (broeks2021inborndisordersof pages 6-10). This thermodynamic coupling ensures a robust unidirectional flow of aspartate out of mitochondria, which is critical for hepatocyte metabolism.
Citrin possesses an unusual three-domain architecture that distinguishes it from most other SLC25 family members (tavoulari2024distinctrolesfor pages 1-2, lacabanne2025currentunderstandingof pages 3-4):
N-terminal calcium-binding domain: This domain contains eight EF-hand motifs, of which only EF-hand 2 possesses a functional calcium-binding site. EF-hands 4–8 do not bind calcium and instead form a dimerization interface (lacabanne2025currentunderstandingof pages 3-4). Importantly, recent work by Tavoulari et al. (2024) has demonstrated that calcium binding to EF-hand 2 is not required for transport regulation. A mutant in which the calcium-binding site was completely abolished (quadruple alanine substitution D66A/T68A/D70A/E77A) retained full transport activity and normal mitochondrial localization (tavoulari2024distinctrolesfor pages 11-12, tavoulari2024distinctrolesfor pages 7-9). The calcium-binding site is now proposed to be an evolutionary remnant (tavoulari2024distinctrolesfor pages 11-12). However, the N-terminal domain plays a critical role in mitochondrial targeting and localization, and pathogenic mutations in this region often cause localization defects rather than transport defects (tavoulari2024distinctrolesfor pages 9-11).
Carrier domain: This is the substrate-transporting module, consisting of three homologous sequence repeats, each containing two transmembrane α-helices connected by a loop harboring a short matrix helix, forming a six-helical bundle with a central water-filled cavity that serves as the substrate translocation pathway (lacabanne2025currentunderstandingof pages 3-4, ruprecht2020theslc25mitochondrial pages 2-3). The carrier operates through an alternating access mechanism, interconverting between a matrix-open (m-state) and a cytoplasmic-open (c-state) conformation. This switching is achieved through coordinated disruption and reformation of salt-bridge networks on either side of the carrier. Three gate elements on the cytoplasmic side and three core elements on the matrix side open and close in alternating fashion to permit substrate binding and translocation (tavoulari2024distinctrolesfor pages 1-2, lacabanne2025currentunderstandingof pages 4-6).
C-terminal amphipathic helix: This short domain contributes to the overall structural integrity and membrane association of the protein (tavoulari2024distinctrolesfor pages 1-2, lacabanne2025currentunderstandingof pages 3-4).
Citrin is unique among SLC25 carriers in that it forms structural homodimers through its N-terminal domains, although the two carrier domains within the dimer appear to function independently rather than cooperatively (tavoulari2024distinctrolesfor pages 11-12, tavoulari2024distinctrolesfor pages 1-2). The full-length atomic structure of citrin has not yet been experimentally resolved, though structural models have been proposed based on domain structures and homology modeling with the ADP/ATP carrier (lacabanne2025currentunderstandingof pages 3-4).
Citrin is localized to the inner mitochondrial membrane, where it mediates metabolite exchange between the mitochondrial matrix and the intermembrane space/cytosol (lacabanne2025currentunderstandingof pages 3-4, gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2).
The tissue expression pattern of citrin is distinctive and has profound implications for disease. In human liver, citrin is the sole or overwhelmingly dominant AGC isoform, with quantitative proteomics revealing a citrin-to-aralar molar ratio of approximately 397:1 (gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2, gonzalezmoreno2023exogenousaralarslc25a12can pages 8-9). This stands in stark contrast to mouse liver, where the ratio is only approximately 8:1, which explains why citrin-knockout mice display a much milder phenotype than human patients with citrin deficiency (gonzalezmoreno2023exogenousaralarslc25a12can pages 8-9, gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2). Beyond liver, citrin is abundantly expressed in intestinal epithelium and is also present in kidney and heart (where it coexists with aralar) (broeks2021inborndisordersof pages 6-10, gonzalezmoreno2023exogenousaralarslc25a12can pages 2-3, ahmed2024theroleof pages 11-13). In the adult brain, citrin expression is extremely low and restricted to discrete neuronal clusters, including the deep cerebellar nuclei, vestibular nuclei, reticular nuclei of the thalamus, reticular tegmental nuclei of the pons, and red magnocellular nuclei (contreras2010lowlevelsof pages 1-2, contreras2010lowlevelsof pages 4-6). No citrin expression is detected in brain glial cells (contreras2010lowlevelsof pages 4-6).
Citrin is the principal component of the malate-aspartate shuttle in hepatocytes, which is the primary mechanism for transferring reducing equivalents (NADH) produced in the cytosol during glycolysis, lactate oxidation, and ethanol oxidation into mitochondria for oxidative phosphorylation (holecek2023aspartateglutamatecarrier2 pages 1-2, gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2). In the MAS, cytosolic NADH reduces oxaloacetate to malate (via cytosolic malate dehydrogenase), malate enters the mitochondrial matrix via the oxoglutarate carrier, and is re-oxidized to oxaloacetate (via mitochondrial malate dehydrogenase), generating mitochondrial NADH. Oxaloacetate is then transaminated to aspartate (via mitochondrial GOT2), and citrin exports aspartate to the cytosol in exchange for glutamate. In the cytosol, aspartate is transaminated back to oxaloacetate, regenerating NAD⁺ (holecek2023aspartateglutamatecarrier2 pages 1-2, broeks2021inborndisordersof pages 6-10). This shuttle is essential for maintaining the cytosolic NAD⁺/NADH redox balance, mitochondrial respiration, and ATP synthesis (holecek2023aspartateglutamatecarrier2 pages 1-2).
Citrin plays a critical role in hepatic ureagenesis by exporting aspartate from mitochondria to the cytosol, where it serves as the substrate for argininosuccinate synthetase (ASS1), the enzyme that condenses aspartate with citrulline to form argininosuccinate (holecek2023aspartateglutamatecarrier2 pages 1-2, cunningham202020000picometersunder pages 4-5). Aspartate provides one of the two nitrogen atoms in the urea molecule (the other being ammonia). When citrin is deficient, cytosolic aspartate availability is reduced, impairing the urea cycle and leading to hyperammonemia and citrullinemia (palmieri2013themitochondrialtransporter pages 15-16, gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2).
Through its role in the MAS, citrin supports gluconeogenesis by facilitating the transfer of aspartate to the cytosol, where it can be transaminated to oxaloacetate—the starting substrate for the gluconeogenic pathway. This linkage is particularly important during starvation, exercise, and amino acid catabolism, when glucagon and catecholamines stimulate both the urea cycle and gluconeogenesis simultaneously (holecek2023aspartateglutamatecarrier2 pages 2-4, lacabanne2025currentunderstandingof pages 3-4).
The cytosolic aspartate supplied by citrin also serves as a precursor for de novo purine and pyrimidine nucleotide biosynthesis and for protein synthesis (palmieri2013themitochondrialtransporter pages 15-16, gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2, owusuansah2023nagscps1and pages 2-4). In cancer biology, citrin-mediated aspartate export has been shown to promote pyrimidine biosynthesis via the CAD complex, supporting tumor cell proliferation (owusuansah2023nagscps1and pages 2-4, owusuansah2023nagscps1and pages 1-2).
The fundamental consequence of citrin function is the maintenance of the cytosolic NAD⁺/NADH ratio, which is essential for glycolysis, gluconeogenesis, and fatty acid β-oxidation. When citrin is absent or dysfunctional, the cytosolic NADH/NAD⁺ ratio becomes elevated, suppressing glycolysis and gluconeogenesis, impairing fatty acid oxidation, and creating a cellular energy deficit (palmieri2013themitochondrialtransporter pages 15-16, nuyttens2025acrucialrole pages 2-3, nuyttens2025acrucialrole pages 9-11). Recent work using Slc25a13⁻/⁻ mice in the context of TNF-induced systemic inflammatory response syndrome (SIRS) has demonstrated that citrin deficiency exacerbates metabolic dysfunction, causing severe hyperlactatemia, hepatic lipid accumulation, and increased lethality through disrupted NAD⁺ regeneration (nuyttens2025acrucialrole pages 2-3, nuyttens2025acrucialrole pages 11-12, nuyttens2025acrucialrole pages 9-11).
A long-standing model held that citrin's transport activity was stimulated by calcium binding to its N-terminal EF-hand domain (goyani2024calciumsignalingin pages 4-6, holecek2023aspartateglutamatecarrier2 pages 2-4). However, landmark recent studies have fundamentally revised this view. Tavoulari et al. (2024) demonstrated, using purified citrin reconstituted in liposomes, that transport activity is not regulated by calcium in vitro (tavoulari2024distinctrolesfor pages 1-2, tavoulari2024distinctrolesfor pages 7-9). Complete abolition of the calcium-binding site had no effect on transport function, mitochondrial localization, or dimerization (tavoulari2024distinctrolesfor pages 7-9). The calcium-binding site in EF-hand 2 is described as non-canonical and pre-formed, and is now proposed to be an evolutionary remnant (tavoulari2024distinctrolesfor pages 11-12). This finding, confirmed by Lacabanne et al. (2025), suggests that calcium does not play a direct role in citrin deficiency pathogenesis and that earlier observations of calcium-dependent activation may have been indirect or related to other regulatory mechanisms (lacabanne2025currentunderstandingof pages 4-6, kunji2025thepeculiarproperties pages 3-4).
Biallelic loss-of-function mutations in SLC25A13 cause citrin deficiency (CD), an autosomal recessive metabolic disorder with three recognized age-dependent phenotypes (vukovic2024thetherapeuticlandscape pages 1-2, komatsu2023citrindeficiencyclinical pages 1-2, kido2024clinicallandscapeof pages 1-2):
NICCD (Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency): Presents in neonates/infants with prolonged jaundice, intrahepatic cholestasis, hepatomegaly, fatty liver, low birth weight, hypoproteinemia, coagulopathy, elevated alpha-fetoprotein, galactosemia, citrullinemia, and hypoglycemia. NICCD typically resolves spontaneously by one year of age, though severe cases may progress to liver failure (vukovic2024thetherapeuticlandscape pages 1-2, komatsu2023citrindeficiencyclinical pages 1-2, kido2022clinicalmanifestationand pages 1-7).
FTTDCD (Failure to Thrive and Dyslipidemia Caused by Citrin Deficiency): A post-NICCD intermediate phenotype characterized by growth impairment, recurrent hypoglycemia, fatigue, hypertriglyceridemia, pancreatitis, and non-obese non-alcoholic fatty liver disease (vukovic2024thetherapeuticlandscape pages 1-2, komatsu2023citrindeficiencyclinical pages 1-2, hayasaka2024pathogenesisandmanagement pages 2-4).
CTLN2/AACD (Adult-Onset Type II Citrullinemia / Adolescent and Adult Citrin Deficiency): The most severe form, developing in approximately 5% of citrin-deficient individuals (typically ages 10–70), characterized by sudden attacks of hyperammonemia, nocturnal encephalopathy, neuropsychological abnormalities including disorientation, abnormal behavior, convulsions, and coma (komatsu2023citrindeficiencyclinical pages 1-2, hayasaka2024pathogenesisandmanagement pages 2-4, kido2022clinicalmanifestationand pages 7-11). Complications include liver cirrhosis and hepatocellular carcinoma (kido2022clinicalmanifestationand pages 7-11).
CD patients characteristically exhibit peculiar dietary preferences, disliking high-carbohydrate foods while preferring fat- and protein-rich foods, which represents a compensatory metabolic adaptation (komatsu2023citrindeficiencyclinical pages 1-2). The disease is highly prevalent in East Asian populations but is now recognized as a pan-ethnic, global condition (kido2024clinicallandscapeof pages 1-2, haberle2024citrindeficiency—theeast‐side pages 1-2). A nationwide Japanese study identified 68 genetic variants across 345 patients, with the c.852_855del variant being the most prevalent, found in 42% of NICCD/post-NICCD cases and 49% of AACD patients (kido2024clinicallandscapeof pages 1-2).
Current treatment includes dietary management (low-carbohydrate, high-fat/protein diet), medium-chain triglyceride (MCT) supplementation, and in severe cases, liver transplantation as the sole curative option (vukovic2024thetherapeuticlandscape pages 1-2, hayasaka2024pathogenesisandmanagement pages 2-4). Gene therapy approaches are under development, including mRNA-based strategies (vukovic2024thetherapeuticlandscape pages 1-2).
Citrin and aralar share 78% sequence identity and perform the same fundamental transport function (aspartate/glutamate exchange), but differ critically in tissue distribution (gonzalezmoreno2023exogenousaralarslc25a12can pages 2-3). Aralar is predominantly expressed in brain, skeletal muscle, and heart, while citrin dominates in liver and intestine (gonzalezmoreno2023exogenousaralarslc25a12can pages 2-3, pardo2022agc1deficiencypathology pages 2-4). In human liver, aralar is virtually absent (citrin:aralar ratio ~400:1), making citrin absolutely indispensable for hepatic metabolism (gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2). Importantly, González-Moreno et al. (2023) demonstrated that exogenous aralar can functionally replace citrin in liver, restoring MAS activity and normalizing NADH/NAD⁺ ratios in citrin-deficient hepatocytes, suggesting a potential therapeutic strategy (gonzalezmoreno2023exogenousaralarslc25a12can pages 8-9, gonzalezmoreno2023exogenousaralarslc25a12can pages 9-10).
Citrin is upregulated in multiple cancer types, including glioblastoma, glioma, stomach adenocarcinoma, and lung adenocarcinoma (1.4- to 4-fold higher expression compared to matched normal tissues) (owusuansah2023nagscps1and pages 2-4). In cancer cells, citrin supports metabolic reprogramming by: (1) maintaining NAD⁺/NADH pools to sustain glycolysis and oxidative phosphorylation; (2) increasing cytosolic aspartate availability for pyrimidine biosynthesis via the CAD complex; and (3) promoting cancer cell migration and invasion through regulation of energy-consuming processes and MMP-9 expression (rabinovich2020themitochondrialcarrier pages 2-4, rabinovich2020themitochondrialcarrier pages 1-2, rabinovich2020themitochondrialcarrier pages 4-5). Citrin overexpression increases lactate production, glycolytic intermediates, and oxygen consumption rates, while citrin depletion restricts these processes (rabinovich2020themitochondrialcarrier pages 4-5). Citrin gene copy number correlates with mRNA expression in several tumor types (owusuansah2023nagscps1and pages 1-2). These findings suggest citrin may represent a novel therapeutic target in cancer (rabinovich2020themitochondrialcarrier pages 2-4, gao2024cancertherapeuticpotential pages 4-6).
SLC25A13/citrin is a mitochondrial inner membrane aspartate/glutamate antiporter of central importance to hepatic metabolism. It exports aspartate from the mitochondrial matrix in exchange for glutamate plus a proton, thereby serving as the key component of the malate-aspartate shuttle in liver. This transport activity is essential for maintaining cytosolic NAD⁺/NADH redox balance, fueling the urea cycle, supporting gluconeogenesis, and providing aspartate for nucleotide and protein biosynthesis. Structurally, citrin is distinguished by its three-domain architecture and homodimeric organization, with recent work overturning the long-held view that calcium regulates its transport activity. Loss-of-function mutations cause citrin deficiency, a clinically complex metabolic disorder with age-dependent hepatic and neurological manifestations, while citrin upregulation in tumors supports cancer cell metabolic reprogramming and proliferation.
References
(palmieri2013themitochondrialtransporter pages 15-16): Ferdinando Palmieri. The mitochondrial transporter family slc25: identification, properties and physiopathology. Molecular aspects of medicine, 34 2-3:465-84, Apr 2013. URL: https://doi.org/10.1016/j.mam.2012.05.005, doi:10.1016/j.mam.2012.05.005. This article has 740 citations and is from a highest quality peer-reviewed journal.
(tavoulari2024distinctrolesfor pages 1-2): Sotiria Tavoulari, Denis Lacabanne, Gonçalo C. Pereira, Chancievan Thangaratnarajah, Martin S. King, Jiuya He, Suvagata R. Chowdhury, Lisa Tilokani, Shane M. Palmer, Julien Prudent, John E. Walker, and Edmund R.S. Kunji. Distinct roles for the domains of the mitochondrial aspartate/glutamate carrier citrin in organellar localization and substrate transport. Dec 2024. URL: https://doi.org/10.1016/j.molmet.2024.102047, doi:10.1016/j.molmet.2024.102047. This article has 12 citations and is from a domain leading peer-reviewed journal.
(kunji2025thepeculiarproperties pages 3-4): E. Kunji, Vasiliki Mavridou, Martin S King, Camila Cimadamore-Werthein, Stephany Jaiquel Baron, Scott A Jones, Alannah C. King, Roger J Springett, Deepak Chand, Shane M Palmer, Denis Lacabanne, Sotiria Tavoulari, and J. Ruprecht. The peculiar properties of mitochondrial carriers of the slc25 family. The Biochemical journal, Jul 2025. URL: https://doi.org/10.1042/bcj20253171, doi:10.1042/bcj20253171. This article has 14 citations.
(ruprecht2020theslc25mitochondrial pages 1-2): Jonathan J. Ruprecht and Edmund R.S. Kunji. The slc25 mitochondrial carrier family: structure and mechanism. Trends in Biochemical Sciences, 45:244-258, Mar 2020. URL: https://doi.org/10.1016/j.tibs.2019.11.001, doi:10.1016/j.tibs.2019.11.001. This article has 440 citations and is from a domain leading peer-reviewed journal.
(gonzalezmoreno2023exogenousaralarslc25a12can pages 2-3): Luis González-Moreno, Andrea Santamaría-Cano, Alberto Paradela, María Luz Martínez-Chantar, Miguel Á. Martín, Mercedes Pérez-Carreras, Alberto García-Picazo, Jesús Vázquez, Enrique Calvo, Gloria González-Aseguinolaza, Takeyori Saheki, Araceli del Arco, Jorgina Satrústegui, and Laura Contreras. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver. Jun 2023. URL: https://doi.org/10.1016/j.ymgmr.2023.100967, doi:10.1016/j.ymgmr.2023.100967. This article has 9 citations.
(holecek2023aspartateglutamatecarrier2 pages 1-2): Milan Holeček. Aspartate-glutamate carrier 2 (citrin): a role in glucose and amino acid metabolism in the liver. BMB Reports, 56:385-391, Jun 2023. URL: https://doi.org/10.5483/bmbrep.2023-0052, doi:10.5483/bmbrep.2023-0052. This article has 5 citations and is from a peer-reviewed journal.
(vukovic2024thetherapeuticlandscape pages 1-2): Toni Vuković, Li Eon Kuek, Barbara Yu, Georgios Makris, and Johannes Häberle. The therapeutic landscape of citrin deficiency. Journal of Inherited Metabolic Disease, 47:1157-1174, Jul 2024. URL: https://doi.org/10.1002/jimd.12768, doi:10.1002/jimd.12768. This article has 14 citations and is from a peer-reviewed journal.
(kido2024clinicallandscapeof pages 1-2): Jun Kido, Georgios Makris, Saikat Santra, and Johannes Häberle. Clinical landscape of citrin deficiency: a global perspective on a multifaceted condition. Journal of Inherited Metabolic Disease, 47:1144-1156, Mar 2024. URL: https://doi.org/10.1002/jimd.12722, doi:10.1002/jimd.12722. This article has 30 citations and is from a peer-reviewed journal.
(lacabanne2025currentunderstandingof pages 3-4): Denis Lacabanne, Alice P. Sowton, Bosco Jose, Edmund R. S. Kunji, and Sotiria Tavoulari. Current understanding of pathogenic mechanisms and disease models of citrin deficiency. Journal of Inherited Metabolic Disease, Mar 2025. URL: https://doi.org/10.1002/jimd.70021, doi:10.1002/jimd.70021. This article has 7 citations and is from a peer-reviewed journal.
(gonzalezmoreno2023exogenousaralarslc25a12can pages 1-2): Luis González-Moreno, Andrea Santamaría-Cano, Alberto Paradela, María Luz Martínez-Chantar, Miguel Á. Martín, Mercedes Pérez-Carreras, Alberto García-Picazo, Jesús Vázquez, Enrique Calvo, Gloria González-Aseguinolaza, Takeyori Saheki, Araceli del Arco, Jorgina Satrústegui, and Laura Contreras. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver. Jun 2023. URL: https://doi.org/10.1016/j.ymgmr.2023.100967, doi:10.1016/j.ymgmr.2023.100967. This article has 9 citations.
(contreras2010lowlevelsof pages 1-2): Laura Contreras, Almudena Urbieta, Keiko Kobayashi, Takeyori Saheki, and Jorgina Satrústegui. Low levels of citrin (slc25a13) expression in adult mouse brain restricted to neuronal clusters. Journal of Neuroscience Research, 88:1009-1016, Apr 2010. URL: https://doi.org/10.1002/jnr.22283, doi:10.1002/jnr.22283. This article has 24 citations and is from a peer-reviewed journal.
(broeks2021inborndisordersof pages 6-10): Melissa H. Broeks, Clara D. M. van Karnebeek, Ronald J. A. Wanders, Judith J. M. Jans, and Nanda M. Verhoeven‐Duif. Inborn disorders of the malate aspartate shuttle. Journal of Inherited Metabolic Disease, 44:792-808, May 2021. URL: https://doi.org/10.1002/jimd.12402, doi:10.1002/jimd.12402. This article has 93 citations and is from a peer-reviewed journal.
(lacabanne2025currentunderstandingof pages 4-6): Denis Lacabanne, Alice P. Sowton, Bosco Jose, Edmund R. S. Kunji, and Sotiria Tavoulari. Current understanding of pathogenic mechanisms and disease models of citrin deficiency. Journal of Inherited Metabolic Disease, Mar 2025. URL: https://doi.org/10.1002/jimd.70021, doi:10.1002/jimd.70021. This article has 7 citations and is from a peer-reviewed journal.
(holecek2023aspartateglutamatecarrier2 pages 2-4): Milan Holeček. Aspartate-glutamate carrier 2 (citrin): a role in glucose and amino acid metabolism in the liver. BMB Reports, 56:385-391, Jun 2023. URL: https://doi.org/10.5483/bmbrep.2023-0052, doi:10.5483/bmbrep.2023-0052. This article has 5 citations and is from a peer-reviewed journal.
(komatsu2023citrindeficiencyclinical pages 1-2): Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, and Masahide Yazaki. Citrin deficiency: clinical and nutritional features. Nutrients, 15:2284, May 2023. URL: https://doi.org/10.3390/nu15102284, doi:10.3390/nu15102284. This article has 19 citations.
(kido2022clinicalmanifestationand pages 7-11): Jun Kido, Johannes Häberle, Keishin Sugawara, Toju Tanaka, Masayoshi Nagao, Takaaki Sawada, Yoichi Wada, Chikahiko Numakura, Kei Murayama, Yoriko Watanabe, Kanako Kojima‐Ishii, Hideo Sasai, Kiyotaka Kosugiyama, and Kimitoshi Nakamura. Clinical manifestation and long‐term outcome of citrin deficiency: report from a nationwide study in japan. Journal of Inherited Metabolic Disease, 45:431-444, Feb 2022. URL: https://doi.org/10.1002/jimd.12483, doi:10.1002/jimd.12483. This article has 39 citations and is from a peer-reviewed journal.
(tavoulari2024distinctrolesfor pages 11-12): Sotiria Tavoulari, Denis Lacabanne, Gonçalo C. Pereira, Chancievan Thangaratnarajah, Martin S. King, Jiuya He, Suvagata R. Chowdhury, Lisa Tilokani, Shane M. Palmer, Julien Prudent, John E. Walker, and Edmund R.S. Kunji. Distinct roles for the domains of the mitochondrial aspartate/glutamate carrier citrin in organellar localization and substrate transport. Dec 2024. URL: https://doi.org/10.1016/j.molmet.2024.102047, doi:10.1016/j.molmet.2024.102047. This article has 12 citations and is from a domain leading peer-reviewed journal.
(tavoulari2024distinctrolesfor pages 7-9): Sotiria Tavoulari, Denis Lacabanne, Gonçalo C. Pereira, Chancievan Thangaratnarajah, Martin S. King, Jiuya He, Suvagata R. Chowdhury, Lisa Tilokani, Shane M. Palmer, Julien Prudent, John E. Walker, and Edmund R.S. Kunji. Distinct roles for the domains of the mitochondrial aspartate/glutamate carrier citrin in organellar localization and substrate transport. Dec 2024. URL: https://doi.org/10.1016/j.molmet.2024.102047, doi:10.1016/j.molmet.2024.102047. This article has 12 citations and is from a domain leading peer-reviewed journal.
(tavoulari2024distinctrolesfor pages 9-11): Sotiria Tavoulari, Denis Lacabanne, Gonçalo C. Pereira, Chancievan Thangaratnarajah, Martin S. King, Jiuya He, Suvagata R. Chowdhury, Lisa Tilokani, Shane M. Palmer, Julien Prudent, John E. Walker, and Edmund R.S. Kunji. Distinct roles for the domains of the mitochondrial aspartate/glutamate carrier citrin in organellar localization and substrate transport. Dec 2024. URL: https://doi.org/10.1016/j.molmet.2024.102047, doi:10.1016/j.molmet.2024.102047. This article has 12 citations and is from a domain leading peer-reviewed journal.
(ruprecht2020theslc25mitochondrial pages 2-3): Jonathan J. Ruprecht and Edmund R.S. Kunji. The slc25 mitochondrial carrier family: structure and mechanism. Trends in Biochemical Sciences, 45:244-258, Mar 2020. URL: https://doi.org/10.1016/j.tibs.2019.11.001, doi:10.1016/j.tibs.2019.11.001. This article has 440 citations and is from a domain leading peer-reviewed journal.
(gonzalezmoreno2023exogenousaralarslc25a12can pages 8-9): Luis González-Moreno, Andrea Santamaría-Cano, Alberto Paradela, María Luz Martínez-Chantar, Miguel Á. Martín, Mercedes Pérez-Carreras, Alberto García-Picazo, Jesús Vázquez, Enrique Calvo, Gloria González-Aseguinolaza, Takeyori Saheki, Araceli del Arco, Jorgina Satrústegui, and Laura Contreras. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver. Jun 2023. URL: https://doi.org/10.1016/j.ymgmr.2023.100967, doi:10.1016/j.ymgmr.2023.100967. This article has 9 citations.
(ahmed2024theroleof pages 11-13): Amer Ahmed, Giorgia Natalia Iaconisi, Daria Di Molfetta, Vincenzo Coppola, Antonello Caponio, Ansu Singh, Aasia Bibi, Loredana Capobianco, Luigi Palmieri, Vincenza Dolce, and Giuseppe Fiermonte. The role of mitochondrial solute carriers slc25 in cancer metabolic reprogramming: current insights and future perspectives. International Journal of Molecular Sciences, 26:92, Dec 2024. URL: https://doi.org/10.3390/ijms26010092, doi:10.3390/ijms26010092. This article has 18 citations.
(contreras2010lowlevelsof pages 4-6): Laura Contreras, Almudena Urbieta, Keiko Kobayashi, Takeyori Saheki, and Jorgina Satrústegui. Low levels of citrin (slc25a13) expression in adult mouse brain restricted to neuronal clusters. Journal of Neuroscience Research, 88:1009-1016, Apr 2010. URL: https://doi.org/10.1002/jnr.22283, doi:10.1002/jnr.22283. This article has 24 citations and is from a peer-reviewed journal.
(cunningham202020000picometersunder pages 4-5): Corey N Cunningham and Jared Rutter. 20,000 picometers under the omm: diving into the vastness of mitochondrial metabolite transport. EMBO reports, Apr 2020. URL: https://doi.org/10.15252/embr.202050071, doi:10.15252/embr.202050071. This article has 48 citations and is from a highest quality peer-reviewed journal.
(owusuansah2023nagscps1and pages 2-4): Melissa Owusu-Ansah, Nikita Guptan, Dylon Alindogan, Michio Morizono, and Ljubica Caldovic. Nags, cps1, and slc25a13 (citrin) at the crossroads of arginine and pyrimidines metabolism in tumor cells. International Journal of Molecular Sciences, 24:6754, Apr 2023. URL: https://doi.org/10.3390/ijms24076754, doi:10.3390/ijms24076754. This article has 16 citations.
(owusuansah2023nagscps1and pages 1-2): Melissa Owusu-Ansah, Nikita Guptan, Dylon Alindogan, Michio Morizono, and Ljubica Caldovic. Nags, cps1, and slc25a13 (citrin) at the crossroads of arginine and pyrimidines metabolism in tumor cells. International Journal of Molecular Sciences, 24:6754, Apr 2023. URL: https://doi.org/10.3390/ijms24076754, doi:10.3390/ijms24076754. This article has 16 citations.
(nuyttens2025acrucialrole pages 2-3): Louise Nuyttens, Marah Heyerick, Maxime Roes, Elise Moens, Céline Van Dender, Charlotte Wallaeys, Tino Hochepied, Steven Timmermans, Jolien Vandewalle, and Claude Libert. A crucial role of the malate aspartate shuttle in metabolic reprogramming in tnf-induced sirs. Frontiers in Immunology, Oct 2025. URL: https://doi.org/10.3389/fimmu.2025.1652516, doi:10.3389/fimmu.2025.1652516. This article has 4 citations and is from a peer-reviewed journal.
(nuyttens2025acrucialrole pages 9-11): Louise Nuyttens, Marah Heyerick, Maxime Roes, Elise Moens, Céline Van Dender, Charlotte Wallaeys, Tino Hochepied, Steven Timmermans, Jolien Vandewalle, and Claude Libert. A crucial role of the malate aspartate shuttle in metabolic reprogramming in tnf-induced sirs. Frontiers in Immunology, Oct 2025. URL: https://doi.org/10.3389/fimmu.2025.1652516, doi:10.3389/fimmu.2025.1652516. This article has 4 citations and is from a peer-reviewed journal.
(nuyttens2025acrucialrole pages 11-12): Louise Nuyttens, Marah Heyerick, Maxime Roes, Elise Moens, Céline Van Dender, Charlotte Wallaeys, Tino Hochepied, Steven Timmermans, Jolien Vandewalle, and Claude Libert. A crucial role of the malate aspartate shuttle in metabolic reprogramming in tnf-induced sirs. Frontiers in Immunology, Oct 2025. URL: https://doi.org/10.3389/fimmu.2025.1652516, doi:10.3389/fimmu.2025.1652516. This article has 4 citations and is from a peer-reviewed journal.
(goyani2024calciumsignalingin pages 4-6): Shanikumar Goyani, Shatakshi Shukla, Pooja Jadiya, and Dhanendra Tomar. Calcium signaling in mitochondrial intermembrane space. Biochemical Society transactions, 52:2215-2229, Oct 2024. URL: https://doi.org/10.1042/bst20240319, doi:10.1042/bst20240319. This article has 11 citations and is from a peer-reviewed journal.
(kido2022clinicalmanifestationand pages 1-7): Jun Kido, Johannes Häberle, Keishin Sugawara, Toju Tanaka, Masayoshi Nagao, Takaaki Sawada, Yoichi Wada, Chikahiko Numakura, Kei Murayama, Yoriko Watanabe, Kanako Kojima‐Ishii, Hideo Sasai, Kiyotaka Kosugiyama, and Kimitoshi Nakamura. Clinical manifestation and long‐term outcome of citrin deficiency: report from a nationwide study in japan. Journal of Inherited Metabolic Disease, 45:431-444, Feb 2022. URL: https://doi.org/10.1002/jimd.12483, doi:10.1002/jimd.12483. This article has 39 citations and is from a peer-reviewed journal.
(hayasaka2024pathogenesisandmanagement pages 2-4): Kiyoshi Hayasaka. Pathogenesis and management of citrin deficiency. Internal Medicine, 63:1977-1986, Jul 2024. URL: https://doi.org/10.2169/internalmedicine.2595-23, doi:10.2169/internalmedicine.2595-23. This article has 18 citations and is from a peer-reviewed journal.
(haberle2024citrindeficiency—theeast‐side pages 1-2): Johannes Häberle. Citrin deficiency—the east‐side story. Journal of Inherited Metabolic Disease, 47:1129-1133, Jul 2024. URL: https://doi.org/10.1002/jimd.12772, doi:10.1002/jimd.12772. This article has 7 citations and is from a peer-reviewed journal.
(pardo2022agc1deficiencypathology pages 2-4): Beatriz Pardo, Eduardo Herrada-Soler, Jorgina Satrústegui, Laura Contreras, and Araceli del Arco. Agc1 deficiency: pathology and molecular and cellular mechanisms of the disease. International Journal of Molecular Sciences, 23:528, Jan 2022. URL: https://doi.org/10.3390/ijms23010528, doi:10.3390/ijms23010528. This article has 32 citations.
(gonzalezmoreno2023exogenousaralarslc25a12can pages 9-10): Luis González-Moreno, Andrea Santamaría-Cano, Alberto Paradela, María Luz Martínez-Chantar, Miguel Á. Martín, Mercedes Pérez-Carreras, Alberto García-Picazo, Jesús Vázquez, Enrique Calvo, Gloria González-Aseguinolaza, Takeyori Saheki, Araceli del Arco, Jorgina Satrústegui, and Laura Contreras. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver. Jun 2023. URL: https://doi.org/10.1016/j.ymgmr.2023.100967, doi:10.1016/j.ymgmr.2023.100967. This article has 9 citations.
(rabinovich2020themitochondrialcarrier pages 2-4): Shiran Rabinovich, Alon Silberman, Lital Adler, Shani Agron, Smadar Levin-Zaidman, Amir Bahat, Ziv Porat, Efrat Ben-Zeev, Inbal Geva, Maxim Itkin, Sergey Malitsky, Adam Buchaklian, Daniel Helbling, David Dimmock, and Ayelet Erez. The mitochondrial carrier citrin plays a role in regulating cellular energy during carcinogenesis. Oncogene, 39:164-175, Aug 2020. URL: https://doi.org/10.1038/s41388-019-0976-2, doi:10.1038/s41388-019-0976-2. This article has 39 citations and is from a domain leading peer-reviewed journal.
(rabinovich2020themitochondrialcarrier pages 1-2): Shiran Rabinovich, Alon Silberman, Lital Adler, Shani Agron, Smadar Levin-Zaidman, Amir Bahat, Ziv Porat, Efrat Ben-Zeev, Inbal Geva, Maxim Itkin, Sergey Malitsky, Adam Buchaklian, Daniel Helbling, David Dimmock, and Ayelet Erez. The mitochondrial carrier citrin plays a role in regulating cellular energy during carcinogenesis. Oncogene, 39:164-175, Aug 2020. URL: https://doi.org/10.1038/s41388-019-0976-2, doi:10.1038/s41388-019-0976-2. This article has 39 citations and is from a domain leading peer-reviewed journal.
(rabinovich2020themitochondrialcarrier pages 4-5): Shiran Rabinovich, Alon Silberman, Lital Adler, Shani Agron, Smadar Levin-Zaidman, Amir Bahat, Ziv Porat, Efrat Ben-Zeev, Inbal Geva, Maxim Itkin, Sergey Malitsky, Adam Buchaklian, Daniel Helbling, David Dimmock, and Ayelet Erez. The mitochondrial carrier citrin plays a role in regulating cellular energy during carcinogenesis. Oncogene, 39:164-175, Aug 2020. URL: https://doi.org/10.1038/s41388-019-0976-2, doi:10.1038/s41388-019-0976-2. This article has 39 citations and is from a domain leading peer-reviewed journal.
(gao2024cancertherapeuticpotential pages 4-6): Renzhuo Gao, Dan Zhou, Xingpeng Qiu, Jiayi Zhang, Daya Luo, Xiaohong Yang, Caiyun Qian, and Zhuoqi Liu. Cancer therapeutic potential and prognostic value of the slc25 mitochondrial carrier family: a review. Cancer Control : Journal of the Moffitt Cancer Center, Jan 2024. URL: https://doi.org/10.1177/10732748241287905, doi:10.1177/10732748241287905. This article has 12 citations.
UniProtKB Q9UJS0. Human liver-type calcium-binding mitochondrial aspartate/glutamate
carrier (AGC2). Paralog of SLC25A12 (aralar / AGC1), the brain/muscle isoform (77% identical).
Falcon deep-research file did not land within the polling window; review grounded in the UniProt
record, the dismech Citrin_Deficiency.yaml disorder model, and cached publications.
id: Q9UJS0
gene_symbol: SLC25A13
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
SLC25A13 encodes citrin (aspartate/glutamate carrier 2, AGC2), the liver-type,
calcium-binding member of the mitochondrial carrier (SLC25) family. It is an
integral, multi-pass protein of the mitochondrial inner membrane that catalyzes
the electrogenic exchange of L-aspartate for L-glutamate plus a proton: it
exports L-aspartate from the mitochondrial matrix to the cytosol while importing
cytosolic L-glutamate together with a proton. Because aspartate moves as the anion
and glutamate is co-transported with a proton, the antiport is electrogenic and, in
energized mitochondria, is driven in the direction of aspartate efflux. Citrin
is a central component of the malate-aspartate NADH shuttle, transferring
cytosolic reducing equivalents into the mitochondria and regenerating cytosolic
NAD+, and it supplies the cytosolic aspartate consumed by argininosuccinate
synthetase (ASS1) in the hepatic urea cycle and used in gluconeogenesis. Each
protomer has a three-domain architecture: an N-terminal regulatory domain with
EF-hand motifs (only EF-hand 2 binds calcium in the intermembrane space), a
six-transmembrane SLC25 carrier domain that performs transport, and a C-terminal
amphipathic helix; the full-length carrier assembles as a homodimer via the
N-terminal domain while transporting substrate as a functional monomer. Citrin is
expressed most abundantly in liver and other non-excitable tissues, in contrast
to its paralog aralar (SLC25A12 / AGC1), the brain- and muscle-predominant
isoform. Loss of citrin function causes citrin deficiency, which manifests across
age as neonatal intrahepatic cholestasis (NICCD), failure to thrive and
dyslipidemia (FTTDCD), and adult-onset citrullinemia type II (CTLN2) with
hyperammonemic encephalopathy; the phenotype is broader than that of a pure urea
cycle enzyme owing to citrin's additional role in the malate-aspartate shuttle
and cellular redox balance.
alternative_products:
- name: '1'
id: Q9UJS0-1
- name: '2'
id: Q9UJS0-2
sequence_note: VSP_043747
existing_annotations:
- term:
id: GO:0005313
label: L-glutamate transmembrane transporter activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic (IBA) assignment of L-glutamate transporter activity. Citrin
imports L-glutamate together with a proton as one half of its aspartate/glutamate
antiport, so this is a correct component of the core function.
action: ACCEPT
reason: >-
Directly supported by experimental reconstitution showing electrogenic exchange
of aspartate for glutamate and a proton. This activity is one arm of the
aspartate/glutamate antiport; the more specific antiporter term (GO:0000515) is
the primary/core molecular function, but this term is accurate.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0015183
label: L-aspartate transmembrane transporter activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic (IBA) assignment of L-aspartate transporter activity. Citrin exports
L-aspartate from the matrix as the other half of its antiport; a correct component
of the core function.
action: ACCEPT
reason: >-
Experimentally demonstrated. Aspartate efflux is one arm of the electrogenic
aspartate/glutamate antiport (the core activity, GO:0000515). This transporter-activity
term is accurate.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0043490
label: malate-aspartate shuttle
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic (IBA) assignment placing citrin in the malate-aspartate NADH shuttle,
which it participates in as the inner-membrane aspartate/glutamate exchange step.
action: ACCEPT
reason: >-
Well supported: overexpression of citrin increases malate-aspartate shuttle activity
in human cells, and the carrier is an integral component of the shuttle. Core biological
process for citrin.
supported_by:
- reference_id: PMID:11566871
supporting_text: "Overexpression of the carriers in transfected human cells increased the activity of the malate/aspartate NADH shuttle"
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetic (IBA) assignment to the mitochondrial inner membrane, where citrin is
active as a multi-pass carrier. Correct and core subcellular location.
action: ACCEPT
reason: >-
Consistent with all experimental localization data and the multi-pass topology of
the SLC25 carrier domain. Core location.
supported_by:
- reference_id: PMID:39419476
supporting_text: "located in the mitochondrial inner membrane"
- term:
id: GO:0015810
label: aspartate transmembrane transport
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic (IBA) BP assignment for aspartate transmembrane transport, the process
arm of citrin's aspartate efflux.
action: ACCEPT
reason: >-
Experimentally supported process term corresponding to the aspartate half of the
antiport. Accurate.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0015813
label: L-glutamate transmembrane transport
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic (IBA) BP assignment for L-glutamate transmembrane transport, the process
arm of citrin's glutamate import.
action: ACCEPT
reason: >-
Experimentally supported process term corresponding to the glutamate half of the
antiport. Accurate.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0000514
label: '3-sulfino-L-alanine: proton, glutamate antiporter activity'
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
ARBA electronic annotation for cysteinesulfinate (3-sulfino-L-alanine) / glutamate,
proton antiport. Citrin exchanges cysteinesulfinate with glutamate and a proton
experimentally; correct but a secondary (non-core) substrate.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally demonstrated as a secondary substrate exchange, but aspartate/glutamate
antiport (GO:0000515) is the physiologically central function. Real but ancillary.
supported_by:
- reference_id: PMID:11566871
supporting_text: "AGC also transports cysteinesulfinate in exchange for either aspartate or glutamate"
- term:
id: GO:0000515
label: aspartate:glutamate, proton antiporter activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
ARBA electronic annotation for the aspartate:glutamate, proton antiporter activity,
the primary catalytic function of citrin. Duplicated by an EXP and an IDA annotation.
action: ACCEPT
reason: >-
The primary/core molecular function of citrin, directly demonstrated by reconstitution
and independently confirmed. The electronic annotation is correct.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic annotation (InterPro EF-hand) for calcium ion binding. Citrin has a
regulatory N-terminal EF-hand domain; the structure confirms calcium binding at EF-hand 2.
action: ACCEPT
reason: >-
Supported by X-ray structure showing calcium bound at EF-hand 2. Calcium binding is a
genuine molecular activity of the regulatory domain.
supported_by:
- reference_id: PMID:25410934
supporting_text: "Only EF-hand 2 binds calcium"
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: >-
Electronic annotation (multiple IEA methods / UniProt SubCell) for mitochondrial inner
membrane localization. Correct and duplicated by EXP/IDA annotations.
action: ACCEPT
reason: >-
Consistent with experimental subcellular localization. Core location.
supported_by:
- reference_id: PMID:39419476
supporting_text: "located in the mitochondrial inner membrane"
- term:
id: GO:0015804
label: neutral amino acid transport
evidence_type: IEA
original_reference_id: GO_REF:0000108
qualifier: involved_in
review:
summary: >-
Inter-ontology (GO_REF:0000108) inference from the cysteinesulfinate antiport term
GO:0000514, classifying cysteinesulfinate transport as neutral amino acid transport.
action: MODIFY
reason: >-
Citrin's physiological substrates aspartate and glutamate are acidic (anionic) amino acids,
not neutral amino acids. This term is a logical by-product of the secondary cysteinesulfinate
activity and mischaracterizes the core function; better captured by the aspartate/glutamate
transport terms.
proposed_replacement_terms:
- id: GO:0015810
label: aspartate transmembrane transport
- id: GO:0015813
label: L-glutamate transmembrane transport
- term:
id: GO:0043490
label: malate-aspartate shuttle
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
ARBA electronic annotation to the malate-aspartate shuttle, duplicating the IBA and IDA
annotations to this term.
action: ACCEPT
reason: >-
Correct; the malate-aspartate shuttle is a core biological process for citrin, independently
supported by experimental data.
supported_by:
- reference_id: PMID:11566871
supporting_text: "Overexpression of the carriers in transfected human cells increased the activity of the malate/aspartate NADH shuttle"
- term:
id: GO:0051592
label: response to calcium ion
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
ARBA electronic annotation for response to calcium ion, reflecting calcium stimulation of
citrin transport activity via its EF-hand domain.
action: KEEP_AS_NON_CORE
reason: >-
Citrin transport is stimulated by calcium binding at the intermembrane-space EF-hand domain,
so a response-to-calcium annotation has an experimental basis. However this is a
regulatory/response process rather than citrin's core transport function. Retain as non-core.
supported_by:
- reference_id: PMID:11566871
supporting_text: "stimulated by Ca"
- term:
id: GO:0055085
label: transmembrane transport
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro2GO electronic annotation to the generic transmembrane transport process from the
mitochondrial carrier domain signature.
action: KEEP_AS_NON_CORE
reason: >-
Correct but very general parent term. The specific aspartate/glutamate transport processes
and the malate-aspartate shuttle capture the core function; this broad term is a valid,
non-core ancestor.
- term:
id: GO:0070778
label: L-aspartate transmembrane transport
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Electronic annotation (from the aspartate transporter/antiporter MF terms) for L-aspartate
transmembrane transport, the process arm of citrin's aspartate efflux.
action: ACCEPT
reason: >-
Accurate specific process term for aspartate transport, consistent with the experimentally
demonstrated aspartate efflux activity.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:1902600
label: proton transmembrane transport
evidence_type: IEA
original_reference_id: GO_REF:0000108
qualifier: involved_in
review:
summary: >-
Inter-ontology inference (from GO:0000514) that citrin is involved in proton transmembrane
transport, reflecting co-transport of a proton with glutamate.
action: KEEP_AS_NON_CORE
reason: >-
Citrin co-transports a proton with glutamate, so proton translocation is part of its
electrogenic mechanism; not wrong, but a mechanistic by-product rather than the primary
amino-acid antiport function. Retain as non-core.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
High-throughput interactome (IPI) annotation with the paralog SLC25A12 / aralar (O75746) as
the recorded partner. Uninformative bare protein-binding term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Per curation guidelines, bare protein binding conveys no specific function. The recorded
partner is the paralog SLC25A12, consistent with the mitochondrial-carrier context, but this
generic term does not describe citrin's molecular function. The informative interaction
(homodimerization) is captured by GO:0042802.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
High-throughput interactome (IPI) annotation with the paralog SLC25A12 (O75746). Uninformative
bare protein-binding term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Bare protein binding is uninformative and is discouraged. Duplicate large-scale interactome hit
against the paralog SLC25A12; does not add functional specificity.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40355756
qualifier: enables
review:
summary: >-
Solute carrier interactome (IPI) annotation with the paralog SLC25A12 (O75746). Uninformative
bare protein-binding term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Bare protein binding is uninformative. Large-scale SLC interactome hit against the paralog
SLC25A12; no specific molecular function conveyed.
- term:
id: GO:0005313
label: L-glutamate transmembrane transporter activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: >-
Ensembl-Compara (GO_REF:0000107) orthology transfer from mouse Slc25a13 (Q9QXX4) of L-glutamate
transporter activity. Duplicates the IBA annotation to this term.
action: ACCEPT
reason: >-
Correct: glutamate import is one arm of citrin's antiport, well supported experimentally. The
orthology transfer is appropriate.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: located_in
review:
summary: >-
Ensembl-Compara orthology transfer of mitochondrion localization. Correct but less specific
than the mitochondrial inner membrane annotations.
action: KEEP_AS_NON_CORE
reason: >-
Accurate but a broad parent of the specific mitochondrial inner membrane location that is the
core annotation. Retain as non-core.
supported_by:
- reference_id: PMID:39419476
supporting_text: "located in the mitochondrial inner membrane"
- term:
id: GO:0006094
label: gluconeogenesis
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Ensembl-Compara orthology transfer for involvement in gluconeogenesis, reflecting the
requirement for cytosolic aspartate (supplied by citrin) in gluconeogenesis from lactate.
action: KEEP_AS_NON_CORE
reason: >-
Citrin-supplied cytosolic aspartate is needed for the conversion of oxoglutarate to
oxaloacetate in gluconeogenesis from lactate/alanine, so the process link is physiologically
valid but downstream and tissue-context dependent rather than a core molecular function.
Retain as non-core.
supported_by:
- reference_id: PMID:25410934
supporting_text: "Cytosolic aspartate is also required for the conversion of oxoglutarate to oxaloacetate, a crucial step in gluconeogenesis from lactate and alanine"
- term:
id: GO:0015172
label: acidic amino acid transmembrane transporter activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: >-
Ensembl-Compara orthology transfer of acidic amino acid transmembrane transporter activity, a
parent term covering the transport of the acidic amino acids aspartate and glutamate.
action: KEEP_AS_NON_CORE
reason: >-
Correct as a broader (parent) molecular function: aspartate and glutamate are acidic amino
acids. The specific aspartate:glutamate antiporter activity (GO:0000515) and the individual
aspartate/glutamate transporter terms are the core annotations; this generalization is a valid
non-core ancestor.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: >-
Immunofluorescence-based (HPA, IDA) mitochondrial localization. Consistent with the established
mitochondrial inner-membrane location.
action: KEEP_AS_NON_CORE
reason: >-
Correct but less specific than mitochondrial inner membrane; retain as non-core. Human Protein
Atlas reports SLC25A13 as tissue-enriched in liver with mitochondrial staining.
- term:
id: GO:0000515
label: aspartate:glutamate, proton antiporter activity
evidence_type: EXP
original_reference_id: PMID:38945283
qualifier: enables
review:
summary: >-
Experimental (EXP) confirmation of aspartate:glutamate, proton antiporter activity. Reconfirmed
the canonical antiport and showed citrin does NOT transport GABA, sharpening substrate specificity.
action: ACCEPT
reason: >-
Directly supports the primary/core molecular function; additionally excludes GABA as a substrate,
refining specificity of the antiport.
supported_by:
- reference_id: PMID:38945283
supporting_text: "the human AGC isoforms (AGC1/aralar1 and AGC2/citrin) are unable to transport GABA both in homo- and in hetero-exchange with either glutamate or aspartate, i.e. the canonical substrates of AGC"
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: EXP
original_reference_id: PMID:10642534
qualifier: located_in
review:
summary: >-
Experimental localization of citrin (Aralar2) to mitochondria in human cell lines. Core location,
duplicated by other EXP/IDA/IBA annotations.
action: ACCEPT
reason: >-
The mitochondrial localization of citrin was experimentally established in this characterization
study; it is the core subcellular location.
supported_by:
- reference_id: PMID:10642534
supporting_text: "The localization of Aralar2/citrin expressed in human cell lines is mitochondrial"
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: EXP
original_reference_id: PMID:39419476
qualifier: located_in
review:
summary: >-
Experimental localization to the mitochondrial inner membrane, from the domain-dissection study
of citrin (which also showed N-terminal mutations cause a mitochondrial import defect). Core location.
action: ACCEPT
reason: >-
Directly supported experimental annotation of the core inner-membrane location.
supported_by:
- reference_id: PMID:39419476
supporting_text: "located in the mitochondrial inner membrane"
- term:
id: GO:0043490
label: malate-aspartate shuttle
evidence_type: IGI
original_reference_id: PMID:37647199
qualifier: involved_in
review:
summary: >-
Genetic-interaction (IGI) annotation from a panel of malate-aspartate-shuttle-deficient cell lines
showing the shuttle (including its AGC component) is important for de novo serine biosynthesis.
Places citrin in the malate-aspartate shuttle.
action: ACCEPT
reason: >-
The malate-aspartate shuttle is a core biological process for citrin. This genetic study of MAS
components (full text assessed by the curator) supports the shuttle involvement; the abstract
confirms the MAS focus. Consistent with the IBA/IDA annotations to the same term.
supported_by:
- reference_id: PMID:37647199
supporting_text: "we show that the MAS is important for de novo serine biosynthesis"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
qualifier: located_in
review:
summary: >-
High-throughput proteomics (HTP) placement of SLC25A13 in the mitochondrion (high-confidence
mitochondrial proteome). Consistent with the established mitochondrial inner-membrane location.
action: KEEP_AS_NON_CORE
reason: >-
Correct but broader than the specific mitochondrial inner-membrane location; a proteome-scale
mitochondrial call. Retain as non-core.
- term:
id: GO:0000514
label: '3-sulfino-L-alanine: proton, glutamate antiporter activity'
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: enables
review:
summary: >-
Direct experimental (IDA) demonstration that citrin exchanges cysteinesulfinate
(3-sulfino-L-alanine) for glutamate and a proton. A genuine but secondary substrate activity.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally demonstrated secondary substrate exchange. Physiologically the aspartate/glutamate
antiport (GO:0000515) is central; cysteinesulfinate exchange is ancillary. Retain as accurate but
non-core.
supported_by:
- reference_id: PMID:11566871
supporting_text: "AGC also transports cysteinesulfinate in exchange for either aspartate or glutamate"
- term:
id: GO:0000515
label: aspartate:glutamate, proton antiporter activity
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: enables
review:
summary: >-
Direct experimental (IDA) demonstration of the electrogenic aspartate:glutamate, proton antiport
by reconstituted citrin. The defining, core molecular function.
action: ACCEPT
reason: >-
The foundational experimental evidence for citrin's core function: reconstituted protein catalyzes
electrogenic exchange of aspartate for glutamate and a proton. Primary molecular function.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: located_in
review:
summary: >-
Direct experimental (IDA) inner-membrane localization with defined multi-pass topology (N- and
C-terminal domains in the intermembrane space; six-TM carrier domain). Core location.
action: ACCEPT
reason: >-
Directly supported experimental annotation of the core inner-membrane location and topology.
supported_by:
- reference_id: PMID:11566871
supporting_text: "Ca(2+)-stimulated aspartate/glutamate transporters"
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IDA
original_reference_id: PMID:25410934
qualifier: enables
review:
summary: >-
Direct experimental (IDA) calcium binding, from the X-ray structure of the citrin N-terminal domain
showing calcium bound at EF-hand 2. Core molecular activity of the regulatory domain.
action: ACCEPT
reason: >-
Crystallographic demonstration of calcium binding at EF-hand 2. Calcium binding by the regulatory
EF-hand domain is a genuine, core molecular function of citrin.
supported_by:
- reference_id: PMID:25410934
supporting_text: "Only EF-hand 2 binds calcium"
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IDA
original_reference_id: PMID:25410934
qualifier: enables
review:
summary: >-
Direct experimental (IDA) identical protein binding, reflecting the demonstrated homodimerization
of citrin via its N-terminal domain (SEC-MALLS and the dimeric crystal structure).
action: KEEP_AS_NON_CORE
reason: >-
Citrin forms a homodimer via the N-terminal domain, so identical protein binding is experimentally
supported and more informative than bare protein binding. However dimerization is a structural
property rather than the core transport function (the carrier transports substrate as a functional
monomer). Retain as non-core.
supported_by:
- reference_id: PMID:25410934
supporting_text: "demonstrating that the full-length carrier was dimeric"
- term:
id: GO:0006839
label: mitochondrial transport
evidence_type: NAS
original_reference_id: PMID:10642534
qualifier: involved_in
review:
summary: >-
Non-traceable author statement (NAS) that citrin functions in mitochondrial transport, from the
initial characterization describing it as a calcium-regulated mitochondrial metabolite carrier.
action: KEEP_AS_NON_CORE
reason: >-
Correct but very general. The specific aspartate/glutamate antiport and its downstream processes
(malate-aspartate shuttle, aspartate/glutamate transport) capture the core function; this broad
process term is a valid non-core ancestor.
supported_by:
- reference_id: PMID:10642534
supporting_text: "function as calcium-regulated metabolite (possibly anionic) carriers"
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-372448
qualifier: located_in
review:
summary: >-
Traceable author statement (Reactome) for mitochondrial inner-membrane localization, from the
Reactome reaction in which SLC25A12/13 exchange L-Glu and L-Asp. Core location.
action: ACCEPT
reason: >-
Reactome curation consistent with all experimental localization data. Core inner-membrane location.
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IDA
original_reference_id: PMID:10642534
qualifier: enables
review:
summary: >-
Direct experimental (IDA) calcium binding from the initial characterization, where the N-terminal
half of citrin was shown to bind calcium (requiring the two most distal EF-hands). Core molecular
activity of the regulatory domain.
action: ACCEPT
reason: >-
Experimentally demonstrated calcium binding by the N-terminal EF-hand domain. Duplicates the
structurally-supported IDA calcium-binding annotation.
supported_by:
- reference_id: PMID:10642534
supporting_text: "The N-terminal half of Aralar2/citrin is able to bind calcium and this requires the presence of the two most distal EF-hands"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:10642534
qualifier: located_in
review:
summary: >-
Direct experimental (IDA) mitochondrial localization of citrin expressed in human cell lines.
Consistent with the inner-membrane location; broader term.
action: KEEP_AS_NON_CORE
reason: >-
Accurate but a broad parent of the specific mitochondrial inner membrane location. Retain as
non-core.
supported_by:
- reference_id: PMID:10642534
supporting_text: "The localization of Aralar2/citrin expressed in human cell lines is mitochondrial"
- term:
id: GO:0005743
label: mitochondrial inner membrane
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
Sequence-similarity (ISS) transfer from mouse Slc25a13 (Q9QXX4) of inner-membrane localization.
Correct and duplicated by EXP/IDA/IBA annotations.
action: ACCEPT
reason: >-
Consistent with all experimental localization data. Core location.
supported_by:
- reference_id: PMID:39419476
supporting_text: "located in the mitochondrial inner membrane"
- term:
id: GO:0005886
label: plasma membrane
evidence_type: NAS
original_reference_id: PMID:10642534
qualifier: located_in
review:
summary: >-
Non-traceable author statement (NAS) placing citrin at the plasma membrane. Contradicts the
extensive experimental evidence for a mitochondrial inner-membrane localization, including the
conclusion of the same cited paper.
action: REMOVE
reason: >-
Citrin is an integral protein of the mitochondrial inner membrane; there is no experimental
support for a plasma-membrane location, and the cited characterization study itself concludes the
localization is mitochondrial. This NAS annotation is inconsistent with established biology and
should be removed.
supported_by:
- reference_id: PMID:10642534
supporting_text: "The localization of Aralar2/citrin expressed in human cell lines is mitochondrial"
- term:
id: GO:0006754
label: ATP biosynthetic process
evidence_type: IDA
original_reference_id: PMID:12851387
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) annotation that recombinant citrin increases mitochondrial ATP production
in agonist-stimulated cells, linking its calcium-sensitive transport activity to mitochondrial
energy metabolism.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally supported: citrin overexpression raises mitochondrial ATP upon calcium-mobilizing
agonist stimulation, via its role in the malate-aspartate shuttle feeding reducing equivalents to
oxidative phosphorylation. This is a downstream physiological consequence rather than citrin's
direct molecular function; retain as non-core.
supported_by:
- reference_id: PMID:12851387
supporting_text: "larger in cells expressing aralar and citrin"
- term:
id: GO:0045333
label: cellular respiration
evidence_type: IDA
original_reference_id: PMID:12851387
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) annotation linking citrin to cellular respiration through its
calcium-stimulated enhancement of mitochondrial ATP production and aerobic metabolism.
action: KEEP_AS_NON_CORE
reason: >-
Citrin contributes to aerobic/oxidative metabolism by feeding cytosolic reducing equivalents into
mitochondria via the malate-aspartate shuttle, and its overexpression stimulates mitochondrial ATP
on agonist stimulation. Downstream physiological role rather than a core molecular function;
retain as non-core.
supported_by:
- reference_id: PMID:12851387
supporting_text: "the stimulation of aerobic metabolism"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: located_in
review:
summary: >-
Direct experimental (IDA) mitochondrial localization from the functional reconstitution study.
Consistent with the inner-membrane location; broader term.
action: KEEP_AS_NON_CORE
reason: >-
Accurate but a broad parent of the specific mitochondrial inner membrane location. Retain as
non-core.
supported_by:
- reference_id: PMID:11566871
supporting_text: "Ca(2+)-stimulated aspartate/glutamate transporters"
- term:
id: GO:0015810
label: aspartate transmembrane transport
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) aspartate transmembrane transport, the process arm of citrin's aspartate
efflux, demonstrated by reconstitution.
action: ACCEPT
reason: >-
Experimentally supported specific process term for aspartate transport (the aspartate half of the
antiport). Accurate.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0015813
label: L-glutamate transmembrane transport
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) L-glutamate transmembrane transport, the process arm of citrin's
glutamate import, demonstrated by reconstitution.
action: ACCEPT
reason: >-
Experimentally supported specific process term for glutamate transport (the glutamate half of the
antiport). Accurate.
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- term:
id: GO:0043490
label: malate-aspartate shuttle
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) annotation to the malate-aspartate shuttle: citrin overexpression
increased malate-aspartate shuttle activity in human cells. Core biological process.
action: ACCEPT
reason: >-
Foundational experimental evidence that citrin is a component of the malate-aspartate NADH shuttle.
Core biological process.
supported_by:
- reference_id: PMID:11566871
supporting_text: "Overexpression of the carriers in transfected human cells increased the activity of the malate/aspartate NADH shuttle"
- term:
id: GO:0051592
label: response to calcium ion
evidence_type: IDA
original_reference_id: PMID:11566871
qualifier: involved_in
review:
summary: >-
Direct experimental (IDA) annotation for response to calcium ion: citrin transport activity is
stimulated by calcium on the external face of the inner membrane, where its EF-hand domains reside.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally supported calcium stimulation of transport, a genuine regulatory response. However
it is a regulatory process rather than citrin's core transport function, and the physiological
significance of the calcium regulation has since been debated. Retain as non-core.
supported_by:
- reference_id: PMID:11566871
supporting_text: "stimulated by Ca"
- term:
id: GO:0000050
label: urea cycle
evidence_type: TAS
original_reference_id: PMID:11566871
qualifier: involved_in
review:
summary: >-
Proposed new annotation. Citrin supplies the cytosolic aspartate consumed by argininosuccinate
synthetase (ASS1) in the hepatic urea cycle; loss of this supply underlies the argininosuccinate
synthetase deficiency and citrullinemia of citrin deficiency. Central role documented but not
currently in the GOA for SLC25A13.
action: NEW
reason: >-
The urea cycle role is a defining, textbook function of citrin and mechanistically explains
citrullinemia type II, yet no urea cycle (GO:0000050) annotation exists in the current GOA. Adding
it captures a core biological process. Supported by the primary functional paper and the structural
review.
supported_by:
- reference_id: PMID:11566871
supporting_text: "urea cycle and the aspartate/malate NADH shuttle"
- reference_id: PMID:25410934
supporting_text: "In liver, cytosolic aspartate is required for the urea cycle"
core_functions:
- description: >-
Electrogenic mitochondrial-inner-membrane aspartate/glutamate antiporter: exports L-aspartate
from the matrix to the cytosol in exchange for cytosolic L-glutamate plus a proton.
molecular_function:
id: GO:0000515
label: aspartate:glutamate, proton antiporter activity
directly_involved_in:
- id: GO:0043490
label: malate-aspartate shuttle
- id: GO:0000050
label: urea cycle
locations:
- id: GO:0005743
label: mitochondrial inner membrane
supported_by:
- reference_id: PMID:11566871
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
- description: >-
Calcium binding by the regulatory N-terminal EF-hand domain (EF-hand 2) in the mitochondrial
intermembrane space, which modulates the carrier.
molecular_function:
id: GO:0005509
label: calcium ion binding
locations:
- id: GO:0005743
label: mitochondrial inner membrane
supported_by:
- reference_id: PMID:25410934
supporting_text: "Only EF-hand 2 binds calcium"
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000108
title: Automatic assignment of GO terms using logical inference, based on on inter-ontology
links
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10642534
title: Characterization of a second member of the subfamily of calcium-binding mitochondrial
carriers expressed in human non-excitable tissues.
findings:
- statement: >-
Cloned citrin (Aralar2) as a liver / non-excitable-tissue calcium-binding mitochondrial
carrier, 78.3% identical to Aralar1; localizes to mitochondria in human cell lines and
binds calcium via its N-terminal EF-hands.
supporting_text: "The localization of Aralar2/citrin expressed in human cell lines is mitochondrial"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-only in cache (full_text_available: false). Original characterization establishing
citrin identity, mitochondrial localization and calcium binding; the plasma-membrane NAS
annotation attributed to this paper contradicts its own mitochondrial conclusion.
- id: PMID:11566871
title: Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters
in mitochondria.
findings:
- statement: >-
Reconstituted citrin catalyzes electrogenic exchange of aspartate for glutamate and a proton,
identifying it as the mitochondrial aspartate/glutamate carrier; overexpression increases
malate-aspartate shuttle activity, and the activity is calcium-stimulated.
supporting_text: "shown to catalyze the electrogenic exchange of aspartate for glutamate and a H"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Full text available and verified. Foundational functional paper for citrin's core molecular
function, malate-aspartate shuttle role, calcium regulation, and urea cycle connection.
- id: PMID:12851387
title: Recombinant expression of the Ca(2+)-sensitive aspartate/glutamate carrier
increases mitochondrial ATP production in agonist-stimulated Chinese hamster ovary
cells.
findings:
- statement: >-
Recombinant citrin (and aralar1) increase mitochondrial ATP production upon calcium-mobilizing
agonist stimulation, linking calcium-sensitive aspartate/glutamate transport to mitochondrial
energy metabolism.
supporting_text: "larger in cells expressing aralar and citrin"
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Abstract-only in cache. Supports the downstream ATP-biosynthesis / cellular-respiration (non-core)
annotations via the calcium-sensitive shuttle role.
- id: PMID:25410934
title: Calcium-induced conformational changes of the regulatory domain of human
mitochondrial aspartate/glutamate carriers.
findings:
- statement: >-
X-ray structures of the citrin/aralar N- and C-terminal domains show a homodimer with a unique
eight-EF-hand arch; only EF-hand 2 binds calcium, and calcium binding opens a vestibule regulating
substrate access.
supporting_text: "Only EF-hand 2 binds calcium"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Full text available. Structural basis for calcium ion binding (IDA) and homodimerization
(identical protein binding, IDA).
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput interactome dataset; supports only a bare protein-binding IPI annotation with the
paralog SLC25A12 (O75746). Not functionally informative for citrin.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput interactome dataset; supports only a bare protein-binding IPI annotation with the
paralog SLC25A12 (O75746).
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Proteome-scale mitochondrial localization evidence (HTP). Supports mitochondrion localization at a
broad level.
- id: PMID:37647199
title: The malate-aspartate shuttle is important for de novo serine biosynthesis.
findings:
- statement: >-
Genetic disruption of malate-aspartate shuttle components (including the aspartate/glutamate carrier)
reduces de novo serine biosynthesis, reflecting the shuttle's role in recycling cytosolic NADH to NAD+.
supporting_text: "we show that the MAS is important for de novo serine biosynthesis"
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Abstract-only in cache (full text not available). Supports the malate-aspartate shuttle involvement
(IGI); assessed as consistent with the well-established shuttle role, deferring to curator judgment on
full text.
- id: PMID:38945283
title: The mitochondrial aspartate/glutamate carrier does not transport GABA.
findings:
- statement: >-
Human citrin (AGC2) and aralar (AGC1) transport aspartate and glutamate but do not transport GABA in
homo- or hetero-exchange, refining the substrate specificity of the aspartate/glutamate antiport.
supporting_text: "the human AGC isoforms (AGC1/aralar1 and AGC2/citrin) are unable to transport GABA both in homo- and in hetero-exchange with either glutamate or aspartate, i.e. the canonical substrates of AGC"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-only in cache. EXP re-confirmation of the aspartate:glutamate antiport (GO:0000515) and
exclusion of GABA as a substrate.
- id: PMID:39419476
title: Distinct roles for the domains of the mitochondrial aspartate/glutamate carrier
citrin in organellar localization and substrate transport.
findings:
- statement: >-
Domain-dissection with 33 pathogenic variants: the carrier domain performs transport (identifying
substrate-binding and dynamics residues), while N-terminal domain mutations cause a mitochondrial
import defect rather than regulating transport via calcium.
supporting_text: "located in the mitochondrial inner membrane"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Full text available. Supports inner-membrane localization (EXP) and reassigns the role of the
N-terminal domain to organellar import; relevant caveat for calcium-regulation annotations.
- id: PMID:40355756
title: The solute carrier superfamily interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale SLC interactome dataset; supports only a bare protein-binding IPI annotation with the
paralog SLC25A12 (O75746).
- id: Reactome:R-HSA-372448
title: SLC25A12,13 exchange L-Glu and L-Asp
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Reactome curation of the aspartate/glutamate exchange, consistent with the core function and
inner-membrane location.